Aromatase inhibitors produce hypersensitivity in experimental models of pain : studies in vivo and in isolated sensory neurons
Indiana University-Purdue University Indianapolis (IUPUI) === Aromatase inhibitors (AIs) are the current standard of care for the treatment of hormone receptor positive breast cancer in postmenopausal women. Nearly one-half of patients receiving AI therapy develop musculoskeletal toxicity that is ch...
Main Author: | Robarge, Jason Dennis |
---|---|
Other Authors: | Flockhart, David A. |
Language: | en_US |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/1805/6056 |
Similar Items
-
Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
by: Tara Hyder, et al.
Published: (2021-07-01) -
Understanding Aromatase: A Mechanistic Basis for Drug Interactions and New Inhibitors
by: Lu, Wenjie
Published: (2012) -
Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects
by: Sara Tenti, et al.
Published: (2020-08-01) -
Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial
by: Inmaculada Conejo, et al.
Published: (2018-06-01) -
Adverse effects of adjuvant endocrine therapy
by: E. I. Kovalenko, et al.
Published: (2018-07-01)